Compare Iron Mountain Inc (IRM) vs ResMed Inc. (RMD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Iron Mountain Inc vs ResMed Inc. — how do they compare? Iron Mountain Inc trades at $127.76 (market cap $36.96B), while ResMed Inc. trades at $197.45 (market cap $28.81B). The key difference: Iron Mountain Inc is the larger of the two by market cap, and Iron Mountain Inc pays the higher dividend (2.78%). Which is the better fit depends on your goals.
| IRM | RMD | |
|---|---|---|
Market Cap | $36.96B | $28.81B |
Sector | Real Estate | Health |
52-Week High | $133.06 | $293.73 |
52-Week Low | $78.86 | $182.82 |
Enterprise Value | $56.10B | $27.99B |
Dividend Yield | 2.78% | 1.21% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Iron Mountain (IRM) trades at $125.56, up 1.41% today, near its recent highs. The stock shows strong momentum with a bullish technical signal and consistent earnings beats. Revenue grew to $6.90B in 2025, though net margins are thin at 3.76%. High debt levels and a P/E of 135.03 present valuation concerns, but analyst consensus is bullish with a $140.50 price target. Recent news highlights institutional activity and data center growth potential.
Outlook remains positive driven by recurring revenue streams and data center expansion, but investors face risks from elevated leverage and interest expenses. The stock offers growth exposure with a dividend, yet requires monitoring of debt management and competitive pressures in information services.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Iron Mountain Inc
Iron Mountain Inc is a record management services provider. The firm is organized as a REIT. Most of its revenue comes from its storage business, with the rest coming from value-added services. The firm primarily caters to enterprise clients in developed markets. Its business segments include Global RIM Business
Read more on IRM →About ResMed Inc.
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.
Read more on RMD →
